孕期糖尿病女性的母乳养经验
Nursing for women's health
|December 30, 2024
概括
患有妊娠糖尿病 (GDM) 的女性面临着巨大的母乳养挑战,并希望得到更多的提供者支持. 了解这些经验对于改善计划母乳养的GDM母亲的护理和支持系统至关重要.
科学领域:
- 围产期健康 围产期健康
- 母婴营养 母婴营养
- 内分泌学 在内分泌学.
背景情况:
- 孕期糖尿病 (GDM) 影响了许多怀孕.
- 为了获得母婴健康益处,鼓励母乳养.
- GDM和母乳养意图的交叉需要进一步探索.
研究的目的:
- 探索被诊断患有GDM的妇女的围产期母乳养经验.
- 确定这些妇女所面临的挑战和促进者.
- 了解医疗保健提供者的感知支持.
主要方法:
- 一个定性描述性研究,利用在线聚焦小组通过Zoom.
- 参与者包括最近患有GDM的妇女,美国的满期分娩,以及分娩后18个月内的妇女.
- 副本被主题分析,以确定关键经验.
主要成果:
- 出现了三个主要主题:挑战 (诊断,怀疑,身体问题,平衡需求,缺乏支持,判断),缺乏提供者信息/支持 (将GDM与母乳养分开,指导不足),以及促进因素 (知识,意图,信心,决心,积极支持).
- 妇女报告说,她们在婴儿养选择方面感到压力和判断.
- 他们表示希望了解更多关于GDM与母乳养的联系的信息.
结论:
- 患有GDM的妇女遇到巨大的母乳养挑战,经常缺乏足够的信息和医疗保健提供者的支持.
- 对养选择的感知压力和判断是显著的.
- 有效的支持系统,无论是面对面还是在线,对于打算母乳养的GDM妇女至关重要.
相关概念视频
Pathophysiology of Diabetes
862
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
862
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Diabetes: Symptoms, Diagnosis, and Complications
503
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
503
Insulin: Dosing Regimen and Adverse Effects
142
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
142
Hypoglycemia and Glucagon
150
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
150


